Skip to main content

Laboratory Corporation of America Holdings Value Stock - Dividend - Research Selection

Laboratory

ISIN: US50540R4092 , WKN: 895308

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates through two segments, LabCorp Diagnostics and Covance Drug Development. It offers a range of clinical laboratory tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, prostate-specific antigen, tests for sexually-transmitted diseases, hepatitis C tests, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by hospitals, physicians and other healthcare providers and commercial clients to assist in the diagnosis, monitoring and treatment of diseases and medical conditions through the examination of substances in blood, tissues, and other specimens. The company also provides specialty testing services in the areas of women\'s health, allergy, diagnostic genetics, cardiovascular disease, infectious disease, endocrinology, oncology, coagulation, pharmacogenetics, toxicology, medical drug monitoring, and pain management; and esoteric testing, cancer diagnostics, and other complex procedures. In addition, it provides drug development solutions and laboratory testing services; and testing services through a sales force to the managed care organizations, biopharmaceutical companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, food and nutritional companies, and independent clinical laboratories. The company has collaboration with university, hospital and academic institutions, such as Boston University, Columbia University, Duke University, Johns Hopkins University, The Mount Sinai Hospital, the University of Tennessee, and Yale University to license and commercialize new diagnostic tests. Laboratory Corporation of America Holdings was founded in 1971 and is headquartered in Burlington, North Carolina.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Barclays Maintains Labcorp Holdings (LH) Equal-Weight Recommendation

2025-10-03

Labcorp Announces Collaboration with Roche to Advance Digital Pathology Capabilities

2025-09-30
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today a collaboration with Roche to implement the company's FDA-cleared VENTANA® DP 600 and DP 200 slide scanners. The investment enables pathologists to diagnose patients using digital images and supports future artificial intelligence (AI) integration.

A Closer Look at Labcorp Holdings (LH) Valuation as Growth Steadily Continues

2025-09-27
Labcorp Holdings (LH) has been on the radar lately, and not necessarily because of a major event shaking the market. Sometimes even subtle moves are enough to make investors take note. Even without a headline-grabbing catalyst, any shift in this stock’s momentum can spark questions about what is driving the narrative and what comes next. For anyone considering what to do with Labcorp Holdings, it might be worth focusing on valuation, since investor attention can lead to real opportunities in...

Labcorp to Announce Third Quarter Financial Results on October 28, 2025

2025-09-25
Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the third quarter of 2025 before the market opens on Tuesday, October 28, 2025. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

2025-09-25
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Labcorp Holdings Inc. (LH) Hit a 52 Week High, Can the Run Continue?

2025-09-24
Labcorp (LH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Reasons to Add Labcorp Stock to Your Portfolio Right Now

2025-09-23
LH's biopharma lab growth and efficiency gains boost momentum, but currency and macro pressures weigh on its outlook.

Labcorp Holdings Stock: Is LH Outperforming the Healthcare Sector?

2025-09-22
Due to Labcorp Holdings’ outperformance relative to the healthcare sector, Wall Street analysts remain strongly optimistic about the stock’s prospects.

Can Danaher's Diagnostics Unit Sustain Growth Amid Lower Sales in China?

2025-09-22
DHR's Diagnostics unit posts steady Q2 growth, led by Beckman Coulter demand, while China headwinds weigh on results.

Here's Why Labcorp Holdings (LH) is a Strong Value Stock

2025-09-18
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.